Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride - PubMed (original) (raw)
Review
Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride
Justin Teiwes et al. Am J Hypertens. 2007 Jan.
Abstract
Amiloride was originally described in 1967 as a potassium-sparing diuretic, the mechanism of action of which is to block the epithelial sodium channel (ENaC) within the distal tubule of the kidney. In addition, higher doses of amiloride were found to be capable of inhibiting the Na(+)/H(+) exchangers (NHE) and the Na(+)/Ca(2+) exchangers. In time, several amiloride analogs have been synthesized to have a marked increase in their specificity to inhibit the ENaC, the NHE or the Na(+)/Ca(2+) exchangers. Although the NHE inhibitors have received the most recent attention, large-scale clinical trials using NHE inhibitors in ischemic cardiac states have shown them to be either ineffective or associated with an unacceptable risk profile. Aldosterone excess in animal models is known to cause cardiovascular injury, and blockade of mineralocorticoid receptors in human beings with heart disease improves outcomes. However, the exact mechanisms of aldosterone injury in animal models of hypertensive disease and protection with mineralocorticoid receptor antagonists in human trials of heart failure remain unknown. These effects are unexplained by changes in BP, potassium, or sodium balance. An additional possibility is that aldosterone action and mineralocorticoid receptor blockade is conferred by alterations in ENaC activity. Emerging experimental evidence suggests the possibility that systemic or central ENaC inhibition or both may be an alternative to the treatment of hypertension and cardiovascular disease states. Clinical trials to evaluate further the potential beneficial cardiovascular effects of ENaC blockade are needed. This article reviews the case for ENaC inhibition as a potential target for cardiovascular and renal protection in human beings.
Similar articles
- Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA. Mall MA. Exp Physiol. 2009 Feb;94(2):171-4. doi: 10.1113/expphysiol.2008.042994. Epub 2008 Dec 5. Exp Physiol. 2009. PMID: 19060118 - The epithelial sodium channel (ENaC): Mediator of the aldosterone response in the vascular endothelium?
Kusche-Vihrog K, Callies C, Fels J, Oberleithner H. Kusche-Vihrog K, et al. Steroids. 2010 Aug-Sep;75(8-9):544-9. doi: 10.1016/j.steroids.2009.09.003. Epub 2009 Sep 22. Steroids. 2010. PMID: 19778545 Review. - Central role for ENaC in development of hypertension.
Pratt JH. Pratt JH. J Am Soc Nephrol. 2005 Nov;16(11):3154-9. doi: 10.1681/ASN.2005050460. Epub 2005 Sep 28. J Am Soc Nephrol. 2005. PMID: 16192416 Clinical Trial. - Mutations in the epithelial Na+ channel ENaC outer pore disrupt amiloride block by increasing its dissociation rate.
Kellenberger S, Gautschi I, Schild L. Kellenberger S, et al. Mol Pharmacol. 2003 Oct;64(4):848-56. doi: 10.1124/mol.64.4.848. Mol Pharmacol. 2003. PMID: 14500741 - The epithelial sodium channel in hypertension: genetic heterogeneity and implications for treatment with amiloride.
Swift PA, MacGregor GA. Swift PA, et al. Am J Pharmacogenomics. 2004;4(3):161-8. Am J Pharmacogenomics. 2004. PMID: 15174897 Review.
Cited by
- Proteolytic Activation of the Epithelial Sodium Channel (ENaC): Its Mechanisms and Implications.
Aufy M, Hussein AM, Stojanovic T, Studenik CR, Kotob MH. Aufy M, et al. Int J Mol Sci. 2023 Dec 16;24(24):17563. doi: 10.3390/ijms242417563. Int J Mol Sci. 2023. PMID: 38139392 Free PMC article. Review. - Mechanism of sorafenib resistance associated with ferroptosis in HCC.
Guo L, Hu C, Yao M, Han G. Guo L, et al. Front Pharmacol. 2023 Jun 7;14:1207496. doi: 10.3389/fphar.2023.1207496. eCollection 2023. Front Pharmacol. 2023. PMID: 37351514 Free PMC article. Review. - Dissociation of sodium-chloride cotransporter expression and blood pressure during chronic high dietary potassium supplementation.
Little R, Murali SK, Poulsen SB, Grimm PR, Assmus A, Cheng L, Ivy JR, Hoorn EJ, Matchkov V, Welling PA, Fenton RA. Little R, et al. JCI Insight. 2023 Mar 8;8(5):e156437. doi: 10.1172/jci.insight.156437. JCI Insight. 2023. PMID: 36719746 Free PMC article. - The Role of Plasma Membrane Sodium/Hydrogen Exchangers in Gastrointestinal Functions: Proliferation and Differentiation, Fluid/Electrolyte Transport and Barrier Integrity.
Nikolovska K, Seidler UE, Stock C. Nikolovska K, et al. Front Physiol. 2022 May 18;13:899286. doi: 10.3389/fphys.2022.899286. eCollection 2022. Front Physiol. 2022. PMID: 35665228 Free PMC article. Review. - Subversion of Phytomyxae Cell Communication With Surrounding Environment to Control Soilborne Diseases; A Case Study of Cytosolic Ca2+ Signal Disruption in Zoospores of Spongospora subterranea.
Amponsah J, Tegg RS, Thangavel T, Wilson CR. Amponsah J, et al. Front Microbiol. 2022 Mar 1;13:754225. doi: 10.3389/fmicb.2022.754225. eCollection 2022. Front Microbiol. 2022. PMID: 35300485 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous